Gouri® Polycaprolactone Injectable Implant is a next-generation injectable implant developed by DexLevo (South Korea). Introduced in 2021, it represents a novel approach to collagen stimulation through a fully liquid form of polycaprolactone, produced using the proprietary CESABP technology.
Unlike conventional PCL-based fillers that contain microspheres or solid particles, Gouri® features fully dissolved PCL, allowing smooth injection and homogeneous distribution within the dermal layers. This formulation supports predictable tissue integration and minimizes the risk of nodules or localized tissue reactions.
Key characteristics of Gouri® Polycaprolactone Injectable Implant include:
- absence of microspheres or solid particles, enabling uniform dermal diffusion;
- high biocompatibility with living tissue;
- gradual biodegradation within the body over approximately 6–24 months;
- stimulation of endogenous collagen production throughout the treated area.
As the PCL matrix gradually degrades, it is replaced by newly formed collagen structures, which may contribute to sustained skin support over time. The product is intended for use in protocols focused on skin quality improvement rather than volumetric correction.
Gouri® Polycaprolactone Injectable Implant is used in professional aesthetic treatments aimed at supporting skin regeneration and improving age-related skin changes without altering facial volume.
It may be applied in protocols addressing:
- fine lines and wrinkles, including periocular and perioral areas;
- nasolabial folds and marionette lines;
- reduced skin firmness and elasticity;
- dryness, rough texture, and uneven skin surface;
- dull or fatigued skin appearance.
Following treatment, the skin may demonstrate:
- gradual improvement in skin density and structural integrity;
- enhanced firmness and elasticity;
- smoother skin texture and more even appearance;
- overall refreshed and rejuvenated look.
A visible tightening effect may be observed shortly after application, while deeper regenerative processes typically develop progressively over several weeks. The duration of the effect varies depending on individual skin condition, treatment technique and lifestyle factors, and may last up to approximately 12 months.
Gouri® Polycaprolactone Injectable Implant – package contents:
- 1 pre-filled sterile glass syringe, 1 ml, individually blister-packed.
Active ingredient:
- Fully dissolved polycaprolactone (PCL) – 210 mg/ml.
Important Notice:
Gouri® Polycaprolactone Injectable Implant is intended exclusively for professional use.
Administration must be performed only by qualified and certified healthcare professionals experienced in injectable aesthetic procedures.
Prior to treatment, an individual consultation is required to assess suitability and exclude contraindications.
This product information is provided for informational purposes only and does not replace professional medical training, diagnosis, or the official manufacturer’s instructions.